The Host Immune Response to Tissue-Engineered Organs: Current Problems and Future Directions. (2016)
Attributed to:
RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/ten.teb.2015.0376
PubMed Identifier: 26701069
Publication URI: http://europepmc.org/abstract/MED/26701069
Type: Journal Article/Review
Volume: 22
Parent Publication: Tissue engineering. Part B, Reviews
Issue: 3
ISSN: 1937-3368